Finance

Lists
Why is HALO up 13,02%?
Dive Deeper
HALO:BMV
Halozyme Therapeutics, Inc.
2 225,00 MX$
+13,02%
(+256,31) 1D
15 հոկ, 14:00:00 GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for HALO...
Open
2 225,00 MX$
High
2 225,00 MX$
Low
2 225,00 MX$
Mkt. cap
13,79 մլրդ
Avg. vol.
440,00
Volume
50,00
52-wk high
2 225,00 MX$
52-wk low
1 126,00 MX$
No. of employees
423
Open
2 225,00 MX$
High
2 225,00 MX$
Low
2 225,00 MX$
Mkt. cap
13,79 մլրդ
Avg. vol.
440,00
Volume
50,00
52-wk high
2 225,00 MX$
52-wk low
1 126,00 MX$
No. of employees
423
News stories
From web sources and news partners
Profile
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
About Halozyme Therapeutics, Inc.
CEOHelen I. Torley
Employees423
Founded1998
HeadquartersՍան Դիեգո, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
354,26 մլն
451,77 մլն
376,71 մլն
481,00 մլն
Cost of goods sold
72,49 մլն
110,67 մլն
104,80 մլն
106,84 մլն
Cost of revenue
72,49 մլն
110,67 մլն
104,80 մլն
106,84 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
46,09 մլն
63,33 մլն
57,88 մլն
57,00 մլն
Operating expense
63,85 մլն
86,70 մլն
87,39 մլն
86,51 մլն
Total operating expenses
136,34 մլն
197,37 մլն
192,19 մլն
193,34 մլն
Operating income
217,92 մլն
254,40 մլն
184,52 մլն
287,65 մլն
Other non operating income
-
-
-
-
EBT including unusual items
218,96 մլն
-100,85 մլն
180,33 մլն
284,90 մլն
EBT excluding unusual items
218,96 մլն
251,58 մլն
180,30 մլն
284,90 մլն
Income tax expense
43,73 մլն
40,74 մլն
30,28 մլն
54,99 մլն
Effective tax rate
19,97%
-40,40%
16,79%
19,30%
Other operating expenses
-
-
-
-
Net income
175,22 մլն
-141,59 մլն
150,05 մլն
229,91 մլն
Net profit margin
49,46%
-31,34%
39,83%
47,80%
Earnings per share
1,72
-0,24
1,60
2,28
Interest and investment income
5,33 մլն
2,09 մլն
1,29 մլն
2,84 մլն
Interest expense
-4,30 մլն
-4,91 մլն
-5,51 մլն
-5,59 մլն
Net interest expenses
1,04 մլն
-2,82 մլն
-4,22 մլն
-2,75 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
236,84 մլն
279,08 մլն
215,65 մլն
319,12 մլն
Gain or loss from assets sale
-
2,62 մլն
-
76,00 հզր
AI content may include mistakes. Learn more
Google Apps